Everything below concerns Nuclear receptor. We keep the language plain, cite what the science says, and separate well-supported claims from open questions.
Updated 2025-10-19. Numbers and descriptions here follow the published literature rather than marketing material.
Laboratory detection of GW501516 commonly uses liquid chromatography coupled with tandem mass spectrometry. The method can identify the parent compound or its metabolites in urine and blood after sample cleanup. Protein precipitation, solid-phase extraction, or enzymatic hydrolysis may precede analysis, depending on the matrix. Reference standards are required for accurate quantification and confirmation. Because the compound is not approved, testing often occurs in anti-doping, forensic, or research settings rather than routine clinical care. Results are reported with limits of detection and quantification.
Stability of GW501516 depends on form, temperature, light exposure, and moisture. Solid reference material is typically stored frozen or refrigerated in a desiccator and protected from light. Solutions in organic solvents such as dimethyl sulfoxide are often kept frozen in aliquots to reduce freeze-thaw cycling. Aqueous solubility is low, so aqueous stock solutions can be difficult to prepare without cosolvents. Degradation may appear as changes in chromatographic purity or mass spectral signal. Stability studies are needed to establish shelf life for any specific preparation.
The pharmacological interest in cardarine centers on PPARδ activation and its downstream effects on lipid handling and mitochondrial function. In animal studies, PPARδ agonists have been associated with changes in exercise endurance and fatty acid utilization, though results vary by model and protocol. Human data remain sparse, and the absence of large controlled trials limits conclusions about efficacy. Researchers often describe the compound as a tool for probing PPARδ biology rather than a proven therapeutic agent.
Safety discussions about cardarine frequently cite rodent carcinogenicity findings reported in the 2000s. In those studies, treated animals developed tumors at multiple sites, leading sponsors to discontinue clinical development. The relevance of these findings to humans has not been resolved, but they are a major reason the compound is not approved. Current literature emphasizes uncertainty about long-term effects and the risks of unregulated use. Regulators and health agencies have not established a safe human exposure level.
Cardarine is a synthetic compound also known as GW501516, GW-501516, and sometimes endurobol. It was developed as a selective agonist of peroxisome proliferator-activated receptor delta, a nuclear receptor involved in fatty acid oxidation and energy metabolism. The compound was studied in preclinical models for metabolic and cardiovascular conditions, but it did not become a marketed human medicine. In regulatory and anti-doping contexts, it is treated as a prohibited substance rather than a licensed medicine.
| Property | Value | Notes |
|---|---|---|
| Appearance | White to off-white powder | Common for reference-grade material. |
| Solubility | Low in water | Dissolves in DMSO and some organic solvents. |
| Typical storage | -20 °C, desiccated | Protect from light and moisture. |
| Analytical method | LC-MS/MS | Used for trace detection in biological matrices. |
| Purity assessment | HPLC with UV detection | Often combined with NMR and mass spectrometry. |
Cardarine is the common name for GW501516, a synthetic compound studied as a peroxisome proliferator-activated receptor delta agonist. Researchers developed it to explore treatments for lipid disorders and metabolic conditions. It is not an approved medicine in any country. Early clinical work examined changes in HDL cholesterol and triglycerides, but development was discontinued after animal studies raised concerns about cancer. The compound remains available as a research chemical and appears in discussions of performance enhancement.
At the molecular level, GW501516 binds and activates PPARδ, a nuclear receptor that regulates transcription. Activation shifts expression of genes involved in fatty acid oxidation, energy expenditure, and lipid transport in skeletal muscle and liver. Animal studies report increased endurance and altered lipid profiles after exposure. Human data are limited to small trials and do not establish long-term safety or efficacy. PPARδ also has roles in cell proliferation, so the relationship between activation and cancer risk remains an open question.
Published literature on cardarine includes in vitro assays, rodent experiments, and a small number of human studies. Reports describe effects on exercise capacity and lipid metabolism in animals, while human evidence is sparse. Many online descriptions present the compound as a proven endurance aid, a claim not supported by regulatory approval or large clinical trials. Analytical studies focus on identifying the parent compound and its metabolites in biological samples. Important uncertainties include species differences, dose-response relationships, and the relevance of rodent tumor findings to humans.
Sporting authorities added GW501516 to prohibited lists after it appeared in athlete samples and online markets. The World Anti-Doping Agency classifies it as a hormone and metabolic modulator, and its use can lead to an anti-doping rule violation. Some early laboratory work suggested effects on fatty acid oxidation and endurance-related metabolism in animals, but those findings do not establish safe or effective use in people. Reports of adverse events in humans are scarce and often anecdotal, which complicates risk assessment.
Legal status varies by country. In some places, cardarine is controlled under medicines or psychoactive substances laws; in others, it may be sold with minimal oversight as a research chemical. Customs agencies have intercepted shipments, and several national health agencies have issued warnings about products marketed for bodybuilding or performance enhancement. The lack of a standardized pharmaceutical supply means identity, purity, and contamination levels can differ widely between samples. These factors make cardarine a regulatory and public health concern rather than a conventional prescription drug.
Cardarine is a common name for GW501516, a synthetic compound first described in the 1990s as a selective agonist of the peroxisome proliferator-activated receptor delta. It was studied in preclinical models for metabolic and cardiovascular conditions, but it has not been approved as a medicine in the United States, Europe, or other major jurisdictions. Retail products labeled as cardarine are generally research chemicals or supplements, not pharmaceutical formulations. Because human safety and efficacy data remain limited, regulatory agencies treat it as an unapproved substance rather than a therapeutic product.
Cardarine can be detected in biological samples and product materials using liquid chromatography coupled to tandem mass spectrometry (LC-MS/MS). The method separates compounds by chromatography and identifies them by mass-to-charge transitions, allowing low-level detection in urine or blood. Sample preparation often involves enzymatic hydrolysis, solid-phase extraction, or protein precipitation. Certified reference materials and isotope-labeled internal standards improve quantification. Detection windows depend on metabolism, matrix, and assay sensitivity, so no single universal window applies.
Regulatory treatment of cardarine differs by context and jurisdiction. In competitive sport, the World Anti-Doping Agency lists PPARδ agonists, including GW501516, as prohibited at all times. Outside sport, it lacks approval as a prescription medicine in major drug markets, and products sold for human consumption may be treated as unapproved drugs. Some countries also restrict importation or sale through general consumer protection and medicines laws. These classifications affect availability, testing, and legal risk without establishing therapeutic value.
Because cardarine is not an approved medicine, no pharmacopeial monograph defines its identity, purity, or storage requirements. Laboratories typically rely on in-house methods and reference standards when testing materials labeled as GW501516. Certificates of analysis may report purity and identity for a specific batch, but their scope varies and they do not guarantee safety or legal status. Independent verification can include high-performance liquid chromatography, mass spectrometry, nuclear magnetic resonance, and elemental analysis. The distinction between research chemical labeling and human use is significant because quality standards and oversight differ.
Anti-doping laboratories detect GW501516 and its metabolites using liquid chromatography-tandem mass spectrometry. Urine is the most common matrix, though blood and dried blood spots may also be used in some programs. Detection depends on factors such as dose, timing, metabolism, and the sensitivity of the assay. Published methods describe limits of detection in the low nanogram per milliliter range for related compounds. Exact detection windows are not fixed for all situations and remain an area of ongoing study.
Products sold as cardarine have been found to contain incorrect compounds, variable amounts, or no active ingredient at all. Independent testing is required to verify identity and purity. Common analytical approaches include high-performance liquid chromatography, mass spectrometry, and nuclear magnetic resonance for structural confirmation. These methods can distinguish GW501516 from related PPAR agonists and from unrelated steroids. For regulators and researchers, such verification is central to interpreting both biological results and adverse event reports.
Cardarine is prohibited in competitive sport under the World Anti-Doping Agency code, where it is classified as a metabolic modulator. It is not approved as a prescription medicine in the United States, European Union, or other major markets. Regulatory action has focused on its presence in sports and in products marketed as research chemicals. Because it has no accepted medical indication, supply is often unregulated. This status creates legal and safety uncertainties for anyone who encounters the substance.
== Nullification == Tensions arose between the Malian government and the Permanent Strategic Framework for Peace, Security, and Development (CSP-PSD), a coalition of the CMA and pro-government militias, in August 2023 following the Malian government and allied Wagner Group's atrocities against civilians. The conflict culminated on August 11, 2023, when CSP-PSD fighters clashed with Mali and Wagner over control of the former MINUSMA base in Ber, which MINUSMA hadn't even finished evacuating. This conflict spiraled into a war between the CSP-PSD and the Malian government, and the nullification of the Algiers Agreement. The Malian government announced its withdrawal from the agreement on January 25, 2024. The government cited the failure of other parties, including Algeria, to uphold the terms of the agreement. Mali's transitional government also accused Algeria of "unfriendly acts" and instrumentalising the accord for its own interests. The Malian authorities further alleged that certain groups, formerly involved in the peace process, had transformed into "terrorist actors" with ties to Algeria.
There are many methods to investigate protein–protein interactions which are the physical contacts of high specificity established between two or more protein molecules. This process typically involves electrostatic forces and hydrophobic effects. Each of the approaches has its own strengths and weaknesses, especially with regard to the sensitivity and specificity of the method. A high sensitivity means that many of the interactions that occur are detected by the screen. A high specificity indicates that most of the interactions detected by the screen are occurring in reality.
== Life == Archerd was always interested in medicine but had neither the discipline nor the money to pursue his interest. In 1940 and 1941, he worked as an assistant at the Camarillo State Mental Hospital in wards where patients were treated with insulin shock therapies. In 1950, he was sentenced to five years of probation for possession of morphine in San Francisco. After another conviction, this parole was revoked. After escaping from a minimum-security prison in Chino, he was rearrested, put in San Quentin Prison, and released again in 1953 on probation. His home was in the Alhambra region of the San Gabriel Valley in Los Angeles County, California.
=== EC 1.2.5 With a quinone or similar compound as acceptor === EC 1.2.5.1: pyruvate dehydrogenase (quinone) EC 1.2.5.2: aldehyde dehydrogenase (quinone) EC 1.2.5.3: aerobic carbon monoxide dehydrogenase
Sources: en.wikipedia.org
The amplitude of an action potential is often thought to be independent of the amount of current that produced it. In other words, larger currents do not create larger action potentials. Therefore, action potentials are said to be all-or-none signals, since either they occur fully or they do not occur at all. This is in contrast to receptor potentials, whose amplitudes are dependent on the intensity of a stimulus. In both cases, the frequency of action potentials is correlated with the intensity of a stimulus. Despite the classical view of the action potential as a stereotyped, uniform signal having dominated the field of neuroscience for many decades, newer evidence does suggest that action potentials are more complex events indeed capable of transmitting information through not just their amplitude, but their duration and phase as well, sometimes even up to distances originally not thought to be possible.
At the 19th Party Congress, Xi stated, "We will fully implement the Party's basic policy on religious affairs, uphold the principle that religions in China must be Chinese in orientation and provide active guidance to religions so that they can adapt themselves to a socialist society."
== External links == American Association of Bioanalysts AAB Associate Member Section American Board of Bioanalysis College of Reproductive Biology Environmental Biology and Public Health Section National Independent Laboratory Association
Sources: en.wikipedia.org
Instant coffee is a beverage derived from processed brewed coffee beans that is quickly prepared by adding hot water or milk to powdered solid coffee extracts. Instant coffee solids in powdered or crystallized form (also called soluble coffee, coffee extract, coffee crystals, coffee powder, or powdered coffee, and often sold as "instant coffee") refers to dehydrated and packaged solids used to make the instant coffee beverage. The product was invented in 1890 in Invercargill, Southland, New Zealand by David Strang. Instant coffee solids are commercially prepared by either freeze-drying or spray drying coffee beverage. Instant coffee is also manufactured in a concentrated liquid form. Instant coffee has advantages over coffee brewed from ground coffee beans including speed of preparation (instant coffee dissolves quickly in hot water), lower shipping weight and volume than beans or ground coffee for the same amount of beverage, and long shelf life—though instant coffee can spoil if not kept dry. However, the beverage made from ground coffee is considered to have superior quality and taste. Instant coffee also reduces cleanup since there are no coffee grounds. At least one study has found that instant coffee has a lower environmental footprint than drip filter coffee and capsule espresso coffee, on a prepared beverage basis, disregarding quality and appeal of the beverage produced. The global instant coffee market was valued at US$4.16 Billion in 2026.
The SADF believed that a covert sabotage operation was possible, as long as the destruction was not attributable to South Africa and a credible cover story could be used to link the attack to a domestic Angolan movement such as UNITA or the Front for the Liberation of the Enclave of Cabinda (FLEC). An attack on the oil platforms was ruled out, as this was beyond the capabilities of either UNITA or FLEC, so the SADF opted to infiltrate the refinery's oil storage facilities and mine the fuel tanks. The damage incurred would cripple Angola's ability to finance its military operations and give it greater economic incentive to accede to South African demands in the ongoing negotiations rather than risk returning to war. The sabotage mission received the code name Operation Argon, and 15 South African special forces operators deployed to Cabinda by sea in May 1985. They were discovered by a FAPLA patrol during the infiltration attempt, and two of the raiders were shot dead with a third, Captain Wynand Petrus du Toit, being captured. Under interrogation, du Toit confessed that the objective of Argon was to sabotage the storage tanks at Cabinda Gulf. The South African government disavowed du Toit and denied responsibility, but General Viljoen later confirmed the SADF's role in the operation. Consequently, the ceasefire imposed as a result of the Lusaka Accords collapsed, and further peace talks were abandoned. The diplomatic repercussions of Operation Argon's failure were immense.
oligo dT A short, single-stranded DNA oligonucleotide consisting of a sequence of repeating deoxythymidine (dT) nucleotides. Oligo dTs are commonly synthesized de novo to be used as primers for in vitro reverse transcription reactions during rtPCR techniques, where short chains of 12 to 18 thymine bases readily complement the poly(A) tails of mature messenger RNAs, allowing the selective amplification and preparation of a cDNA library from a pool of coding transcripts.
=== Importance of resistivity === In an imperfectly conducting fluid, the magnetic field can generally move through the fluid according to a diffusion law, with the resistivity of the plasma serving as a diffusion constant. This means that solutions to the ideal MHD equations are applicable only for a limited time within a region of a given size before diffusion becomes too significant to ignore. One can estimate the diffusion time across a solar active region (from collisional resistivity) to be hundreds to thousands of years, much longer than the actual lifetime of a sunspot, so it would seem reasonable to ignore the resistivity. By contrast, a meter-sized volume of seawater has a magnetic diffusion time measured in milliseconds. Even in physical systems that are large and conductive enough that simple estimates of the Lundquist number suggest that the resistivity can be ignored, resistivity may still be important: many instabilities can increase the effective resistivity of the plasma by factors greater than 109. The enhanced resistivity is usually the result of the formation of small-scale structures such as current sheets or fine-scale magnetic turbulence, introducing small spatial scales into the system over which ideal MHD breaks down and magnetic diffusion can occur rapidly. When this happens, magnetic reconnection may occur in the plasma, releasing stored magnetic energy as waves, bulk mechanical acceleration of material, particle acceleration, and heat.
Sources: en.wikipedia.org
LC-MS/MS is common, often after sample cleanup. The assay targets GW501516 or its metabolites.
Reference material is usually kept cold, dry, and protected from light. Frozen aliquots reduce repeated freeze-thaw cycles.
No approved pharmaceutical product exists, so manufacturing and quality controls are not standardized. Products may contain different compounds or impurities.
Cardarine is an investigational synthetic compound that acts as a PPARδ agonist. It is also known as GW501516 and has been studied mainly in preclinical research. It is not an approved medicine.